INNOSPEC INC. Revenue
INNOSPEC INC. (IOSP) reported Revenue of $491.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-05
- INNOSPEC INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $491.40M, a 11.76% increase year-over-year.
- INNOSPEC INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $453.20M, a 2.81% increase year-over-year.
- INNOSPEC INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $455.60M, a 2.40% decline year-over-year.
- INNOSPEC INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $441.90M, a 0.34% decline year-over-year.
- INNOSPEC INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $1.78B, a 3.65% decline from fiscal 2024.
- INNOSPEC INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.85B, a 5.31% decline from fiscal 2023.
- INNOSPEC INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.95B, a 0.76% decline from fiscal 2022.
- INNOSPEC INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $1.96B, a 32.38% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $491.40M 10-Q · filed 2026-08-05 | $944.60M 10-Q · filed 2026-08-05 | $1.40B derived: sum of 3 quarters · filed 2026-08-05 | $1.84B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $453.20M 10-Q · filed 2026-05-08 | $908.80M derived: sum of 2 quarters · filed 2026-05-08 | $1.35B derived: sum of 3 quarters · filed 2026-05-08 | $1.79B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $455.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $897.50M derived: sum of 2 quarters · filed 2026-02-18 | $1.34B derived: sum of 3 quarters · filed 2026-08-05 | $1.78B 10-K · filed 2026-02-18 |
| 2025-09-30 | $441.90M 10-Q · filed 2025-11-05 | $881.60M derived: sum of 2 quarters · filed 2026-08-05 | $1.32B 10-Q · filed 2025-11-05 | $1.79B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $439.70M 10-Q · filed 2026-08-05 | $880.50M 10-Q · filed 2026-08-05 | $1.35B derived: sum of 3 quarters · filed 2026-08-05 | $1.79B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $440.80M 10-Q · filed 2026-05-08 | $907.60M derived: sum of 2 quarters · filed 2026-05-08 | $1.35B derived: sum of 3 quarters · filed 2026-05-08 | $1.79B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $466.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $910.20M derived: sum of 2 quarters · filed 2026-02-18 | $1.35B derived: sum of 3 quarters · filed 2026-02-18 | $1.85B 10-K · filed 2026-02-18 |
| 2024-09-30 | $443.40M 10-Q · filed 2025-11-05 | $878.40M derived: sum of 2 quarters · filed 2025-11-05 | $1.38B 10-Q · filed 2025-11-05 | $1.87B derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $435.00M 10-Q · filed 2025-08-06 | $935.20M 10-Q · filed 2025-08-06 | $1.43B derived: sum of 3 quarters · filed 2026-02-18 | $1.89B derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $500.20M 10-Q · filed 2025-05-09 | $994.90M derived: sum of 2 quarters · filed 2026-02-18 | $1.46B derived: sum of 3 quarters · filed 2026-02-18 | $1.94B derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $494.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $958.80M derived: sum of 2 quarters · filed 2026-02-18 | $1.44B derived: sum of 3 quarters · filed 2026-02-18 | $1.95B 10-K · filed 2026-02-18 |
| 2023-09-30 | $464.10M 10-Q · filed 2024-11-06 | $944.50M derived: sum of 2 quarters · filed 2024-11-06 | $1.45B 10-Q · filed 2024-11-06 | $1.96B derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $480.40M 10-Q · filed 2024-08-07 | $990.00M 10-Q · filed 2024-08-07 | $1.50B derived: sum of 3 quarters · filed 2025-02-19 | $2.01B derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $509.60M 10-Q · filed 2024-05-10 | $1.02B derived: sum of 2 quarters · filed 2025-02-19 | $1.53B derived: sum of 3 quarters · filed 2025-02-19 | $2.00B derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $510.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $1.02B derived: sum of 2 quarters · filed 2025-02-19 | $1.49B derived: sum of 3 quarters · filed 2025-02-19 | $1.96B 10-K · filed 2025-02-19 |
| 2022-09-30 | $513.00M 10-Q · filed 2023-11-08 | $980.60M derived: sum of 2 quarters · filed 2023-11-08 | $1.45B 10-Q · filed 2023-11-08 | $1.87B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $467.60M 10-Q · filed 2023-08-09 | $940.00M 10-Q · filed 2023-08-09 | $1.35B derived: sum of 3 quarters · filed 2024-02-14 | $1.73B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $472.40M 10-Q · filed 2023-05-04 | $885.60M derived: sum of 2 quarters · filed 2024-02-14 | $1.26B derived: sum of 3 quarters · filed 2024-02-14 | $1.62B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $413.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $789.30M derived: sum of 2 quarters · filed 2024-02-14 | $1.14B derived: sum of 3 quarters · filed 2024-02-14 | $1.48B 10-K · filed 2024-02-14 |
| 2021-09-30 | $376.10M 10-Q · filed 2022-11-09 | $730.60M derived: sum of 2 quarters · filed 2022-11-09 | $1.07B 10-Q · filed 2022-11-09 | $1.38B derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $354.50M 10-Q · filed 2022-08-03 | $694.10M 10-Q · filed 2022-08-03 | $1.00B derived: sum of 3 quarters · filed 2023-02-22 | $1.27B derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $339.60M 10-Q · filed 2022-05-04 | $650.40M derived: sum of 2 quarters · filed 2023-02-22 | $915.50M derived: sum of 3 quarters · filed 2023-02-22 | $1.16B derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $310.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $575.90M derived: sum of 2 quarters · filed 2023-02-22 | $820.80M derived: sum of 3 quarters · filed 2023-02-22 | $1.19B 10-K · filed 2023-02-22 |
| 2020-09-30 | $265.10M 10-Q · filed 2021-11-03 | $510.00M derived: sum of 2 quarters · filed 2021-11-03 | $882.30M 10-Q · filed 2021-11-03 | $1.27B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $244.90M 10-Q · filed 2021-08-04 | $617.20M 10-Q · filed 2021-08-04 | $1.01B derived: sum of 3 quarters · filed 2022-02-16 | $1.38B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $372.30M 10-Q · filed 2021-05-05 | $763.00M derived: sum of 2 quarters · filed 2022-02-16 | $1.13B derived: sum of 3 quarters · filed 2022-02-16 | $1.50B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $390.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $762.60M derived: sum of 2 quarters · filed 2022-02-16 | $1.13B derived: sum of 3 quarters · filed 2022-02-16 | $1.51B 10-K · filed 2022-02-16 |
| 2019-09-30 | $371.90M 10-Q · filed 2020-11-04 | $734.30M derived: sum of 2 quarters · filed 2020-11-04 | $1.12B 10-Q · filed 2020-11-04 | $1.52B derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $362.40M 10-Q · filed 2020-08-05 | $750.70M 10-Q · filed 2020-08-05 | $1.15B derived: sum of 3 quarters · filed 2021-02-17 | $1.51B derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $388.30M 10-Q · filed 2020-05-06 | $783.30M derived: sum of 2 quarters · filed 2021-02-17 | $1.15B derived: sum of 3 quarters · filed 2021-02-17 | $1.50B derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | $395.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $758.10M derived: sum of 2 quarters · filed 2021-02-17 | $1.12B derived: sum of 3 quarters · filed 2021-02-17 | $1.48B 10-K · filed 2021-02-17 |
| 2018-09-30 | $363.10M 10-Q · filed 2019-11-06 | $721.20M derived: sum of 2 quarters · filed 2019-11-06 | $1.08B 10-Q · filed 2019-11-06 | $1.44B derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $358.10M 10-Q · filed 2019-08-06 | $718.80M 10-Q · filed 2019-08-06 | $1.07B derived: sum of 3 quarters · filed 2020-02-19 | $1.41B derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $360.70M 10-Q · filed 2019-05-08 | $714.50M derived: sum of 2 quarters · filed 2020-02-19 | $1.05B derived: sum of 3 quarters · filed 2020-02-19 | $1.37B derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $353.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $686.20M derived: sum of 2 quarters · filed 2020-02-19 | $1.01B derived: sum of 3 quarters · filed 2020-02-19 | $1.31B 10-K · filed 2020-02-19 |
| 2017-09-30 | $332.40M 10-Q · filed 2018-11-07 | $658.70M derived: sum of 2 quarters · filed 2018-11-07 | $953.00M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $326.30M 10-Q · filed 2018-08-08 | $620.60M 10-Q · filed 2018-08-08 | ||
| 2016-12-31 | $883.40M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| Perimeter Solutions, Inc. (PRM) | $4.593B | -17.21 | |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |
| CitroTech Inc. (CITR) | United States | $0.097B | -5.12 |
| Loop Industries, Inc. (LOOP) | $0.023B | -5.50 |